{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-24-000028","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.158240+00:00","generated_at":"2026-05-31T12:00:48.135021+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"ICU Medical Q2 revenue up 8.6% to $596.5M but GAAP net loss widens to $21.4M; adjusted EPS down to $1.56","bullets":["Revenue $596.5M up 8.6% YoY from $549.3M; GAAP gross margin 35% unchanged.","GAAP net loss $(21.4)M ($0.88 loss per diluted share) vs $(9.9)M loss ($0.41) in Q2 2023.","Adjusted diluted EPS $1.56 vs $1.88 YoY; adjusted EBITDA $91.3M down from $98.1M.","Fiscal 2024 guidance updated; details not included in this excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-24-000028","json":"https://secwatch.observer/filing/0000883984-24-000028.json","markdown":"https://secwatch.observer/filing/0000883984-24-000028.md","text":"https://secwatch.observer/filing/0000883984-24-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000028/0000883984-24-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000028/icui-20240807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:00:48.135021+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}